BCHE and spondylo-ocular syndrome: In conclusion, we suggest that it could be reasonable to start a prophylactic therapy with defibrotide at the first signs of hepatic dysfunction, even before official diagnostic criteria for SOS are met, in patients at high risk for liver complications in whom a drop in BChE activity values <1800 UI/L is detected.